View : 461 Download: 0
Velcade (R), thalidomide, dexamethasone (VTD) induction therapy followed by melphalan, prednisone, thalidomide (MPT) maintenance as a first line treatment for the patients (pts) with multiple myeloma (MM) who are non-transplant candidates: Early analysis from the Korean multiple myeloma working party
- Title
- Velcade (R), thalidomide, dexamethasone (VTD) induction therapy followed by melphalan, prednisone, thalidomide (MPT) maintenance as a first line treatment for the patients (pts) with multiple myeloma (MM) who are non-transplant candidates: Early analysis from the Korean multiple myeloma working party
- Authors
- Eom, HyeonSeok; Kim, Yeo-Kyeoung; Chung, Jooseop; Kim, Kihyun; Kim, HyoJeong; Jin, JongYul; Do, Young-Rok; Oh, Sukjoong; Kim, HoYoung; Suh, Cheolwon; Seong, Chu-Myong; Kim, Chul Soo; Lee, Dong Soon; Lee, Jae Hoon
- Ewha Authors
- 성주명
- SCOPUS Author ID
- 성주명

- Issue Date
- 2007
- Journal Title
- BLOOD
- ISSN
- 0006-4971
- Citation
- BLOOD vol. 110, no. 11, pp. 282B - 282B
- Publisher
- AMER SOC HEMATOLOGY
- Indexed
- SCI; SCIE; SCOPUS

- Document Type
- Meeting Abstract
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML